GGrantIndex
Sort

23,748 grants matching melanoma

The regulation of melanocyte stem cells by Wnt signaling

$380,250
Mayumi Ito · New York University School Of Medicine · R01 · FY2015 · AR

The regulation of melanocyte stem cells by Wnt signaling

$380,250
Mayumi Ito · New York University School Of Medicine · R01 · FY2012 · AR

Functional precision approaches to overcome intrinsic and acquired drug resistance in melanoma

$380,225
Jessie Villanueva · Wistar Institute · U54 · FY2024 · CA

Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity

$380,128
Eric Meggers · Wistar Institute · P01 · FY2008 · CA

Selective Targeting Survivin for Cancer Therapy

$380,127
Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2020 · CA

Selective Targeting Survivin for Cancer Therapy

$380,127
Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2017 · CA

Selective Targeting Survivin for Cancer Therapy

$380,127
Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2018 · CA

Phosphoinositide Signaling Regulates Melanogenesis

$380,102
Anand K Ganesan · University Of California-Irvine · R01 · FY2015 · AR

Cancer and Leukemia Group B - The Ohio State University

$380,084
Ohio State University · U10 · FY2005 · CA

Imaging Mitochondrial Redox States In Vivo by Hyperpolarized MR

$380,028
Lin Z Li · University Of Pennsylvania · R01 · FY2015 · CA

Phosphoinositide Signaling Regulates Melanogenesis

$380,010
Anand K Ganesan · University Of California-Irvine · R01 · FY2014 · AR

Uncover the new subsets of epidermal Langerhans cells

$380,000
Qing-Sheng Mi · Henry Ford Health System · R33 · FY2021 · AR

GMPS-GMPR axis melanoma progression and therapy

$379,998
Mikhail Nikiforov · Wake Forest University Health Sciences · R01 · FY2020 · CA

Differential role of different NAD+ kinase Isoforms in melanoma metastasis

$379,977
Elena Piskounova · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Investigating T Cell Egress via Lymphatic Vessels in Melanoma

$379,977
Amanda W. Lund · New York University School Of Medicine · R01 · FY2023 · CA

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

$379,970
Ann Richmond · Vanderbilt University · R01 · FY2021 · CA

Role of AP-3 in protein sorting and autophagy in melanosome biogenesis

$379,914
Megan Kathleen Dennis · Marist College · R15 · FY2019 · GM

A Nuclear Receptor COUP-TFII in Vascular Function: Angiogenesis and Tumoirgenesis

$379,913
Sophia Y Tsai · Baylor College Of Medicine · R01 · FY2012 · HL

EASTERN COOPERATIVE ONCOLOGY GROUP STUDIES

$379,895
Case Western Reserve University · U10 · FY2002 · CA

Molecular Pathophysiology of Thyroid Cell Growth

$379,852
James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA

Phase II trial of 17-AAG in melanoma patients

$379,836
Paul B Chapman · Sloan-Kettering Inst Can Research · R21 · FY2006 · CA

Antigenic Determinants on HLA-B7 and -A2

$379,773
Victor H. Engelhard · University Of Virginia · R01 · FY2008 · CA

Adhesive Signaling by Platelet Integrins

$379,750
Sanford J Shattil · University Of California, San Diego · R01 · FY2014 · HL

Regulation of the Hippo pathway and its role in uveal melanoma

$379,750
Kun-Liang Guan · University Of California, San Diego · R01 · FY2015 · EY

Regulation of the Hippo pathway and its role in uveal melanoma

$379,750
Kun-Liang Guan · University Of California, San Diego · R01 · FY2014 · EY